NEW YORK — French single-cell analysis technology startup Minos Biosciences said on Thursday that it has raised €1.5 million ($1.8 million) in seed funding.
The financing was led by VC firm Elaia Partners through its investment venture with Université Paris Sciences et Lettres (Université PSL).
Minos was founded in 2020 as a spinoff from the Ecole Supérieure de Physique et Chimie Industrielles de Paris (ESPCI Paris – PSL) to develop a high-throughput single-cell analysis platform based on microfluidics, molecular biology, image analysis, and bioinformatic technologies. It has been housed at PC'up Boost, the ESPCI Paris – PSL incubator at the Institut Pierre-Gilles de Gennes.
"The seed round … will allow Minos to considerably accelerate its development by reinforcing its R&D team, developing its first prototype, and validating its first applications in close collaboration with top academic laboratories and institutions," Minos Chief Operating Officer Pierre Le Ber said in a statement. "It will also allow Minos to prepare the industrial prototyping phase of its solution."